These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12211522)

  • 1. Beta-blockers have beneficial effects even on unclassified cardiomyopathy such as isolated ventricular noncompaction.
    Takano H; Komuro I
    Intern Med; 2002 Aug; 41(8):601-2. PubMed ID: 12211522
    [No Abstract]   [Full Text] [Related]  

  • 2. Carvedilol-induced changes in cardiac diastolic performance in a patient with isolated noncompaction of the myocardium.
    Harada T; Ohtaki E; Kitahara K; Sumiyoshi T; Hosoda S
    Intern Med; 2002 Aug; 41(8):642-7. PubMed ID: 12211534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol.
    Mukai Y; Yoshida T; Nakaike R; Mukai N; Iwato K; Kyo T; Kaseda S
    Intern Med; 2004 Nov; 43(11):1087-8. PubMed ID: 15609710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers and ventricular arrhythmias in dilated cardiomyopathy.
    Fauchier L; Giraudeau B
    J Am Coll Cardiol; 2000 Jun; 35(7):1993-4. PubMed ID: 10841254
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.
    Okafor CC; Perreault-Micale C; Hajjar RJ; Lebeche D; Skiroman K; Jabbour G; Doye AA; Lee MX; Laste N; Gwathmey JK
    BMC Physiol; 2003 Jul; 3():6. PubMed ID: 12873352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of left ventricular parameters following combined pimobendan and carvedilol treatment in a case of unclassified cardiomyopathy with longstanding refractory status.
    Takeda N; Ohtaki E; Misu K; Asano R; Tobaru T; Nagayama M; Kitahara K; Umemura J; Sumiyoshi T; Hosoda S
    Intern Med; 2002 Dec; 41(12):1147-52. PubMed ID: 12521204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Lee YC
    Am J Cardiol; 1997 Apr; 79(7):1001. PubMed ID: 9104927
    [No Abstract]   [Full Text] [Related]  

  • 8. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
    Wright DJ; Cooke GA; Tan LB
    Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined alpha and beta blockers in the therapy of cardiovascular diseases].
    Tavciovski D; Romanović R; Bosković S; Duran P; Matunović R
    Vojnosanit Pregl; 2002; 59(4):405-10. PubMed ID: 12235748
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blockade in adriamycin-induced cardiomyopathy.
    Noori A; Lindenfeld J; Wolfel E; Ferguson D; Bristow MR; Lowes BD
    J Card Fail; 2000 Jun; 6(2):115-9. PubMed ID: 10908085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
    Yildirir A; Sade E; Tokgozoglu L; Oto A
    Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
    Böhm M; Ettelbrück S; Flesch M; van Gilst WH; Knorr A; Maack C; Pinto YM; Paul M; Teisman AC; Zolk O
    Cardiovasc Res; 1998 Oct; 40(1):146-55. PubMed ID: 9876327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two different cardiomyopathies in a single patient : hypertrophic cardiomyopathy and left ventricular noncompaction.
    Sunbul M; Ozben B; Mutlu B
    Herz; 2013 May; 38(3):313-6. PubMed ID: 23263242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol outclasses the other beta-blockers.
    Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
    Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
    Böhm M; Erdmann E
    Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
    [No Abstract]   [Full Text] [Related]  

  • 18. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of carvedilol in pediatric heart failure.
    Christensen AH; Fatkin D
    Future Cardiol; 2013 Jul; 9(4):475-8. PubMed ID: 23834688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.